Toxins 2011, 3(3), 191-200; doi:10.3390/toxins3030191
Review

Monitoring Radiographic Brain Tumor Progression

Received: 31 January 2011; in revised form: 3 February 2011 / Accepted: 11 March 2011 / Published: 15 March 2011
(This article belongs to the Special Issue Immunotoxins)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Determining radiographic progression in primary malignant brain tumors has posed a significant challenge to the neuroncology community. Glioblastoma multiforme (GBM, WHO Grade IV) through its inherent heterogeneous enhancement, growth patterns, and irregular nature has been difficult to assess for progression. Our ability to detect tumor progression radiographically remains inadequate. Despite the advanced imaging techniques, detecting tumor progression continues to be a clinical challenge. Here we review the different criteria used to detect tumor progression, and highlight the inherent challenges with detection of progression.
Keywords: glioblastoma; radiographic progression; tumor progression; MRI
PDF Full-text Download PDF Full-Text [190 KB, uploaded 15 March 2011 10:58 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Mehta, A.I.; Kanaly, C.W.; Friedman, A.H.; Bigner, D.D.; Sampson, J.H. Monitoring Radiographic Brain Tumor Progression. Toxins 2011, 3, 191-200.

AMA Style

Mehta AI, Kanaly CW, Friedman AH, Bigner DD, Sampson JH. Monitoring Radiographic Brain Tumor Progression. Toxins. 2011; 3(3):191-200.

Chicago/Turabian Style

Mehta, Ankit I.; Kanaly, Charles W.; Friedman, Allan H.; Bigner, Darell D.; Sampson, John H. 2011. "Monitoring Radiographic Brain Tumor Progression." Toxins 3, no. 3: 191-200.

Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert